P2X receptors and inflammation

Current Medicinal Chemistry

Volumn 22, Issue 7, 2015, Pages 866-877

  Di Virgilio, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Extracellular ATP; Innate immunity; P2X4; P2X7; Purinergic receptors

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CRYOPYRIN; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X5 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; SERUM AMYLOID A; TOLL LIKE RECEPTOR; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANALGESIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; GIANT CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MECHANICAL STRESS; MONONUCLEAR PHAGOCYTE; NOCICEPTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE REGENERATION; ANIMAL; METABOLISM;

ANIMALS; HUMANS; INFLAMMATION; RECEPTORS, PURINERGIC P2X;

EID: 84926471604     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666141210155311     Document Type: Article

References (162)

1. Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev., 2007, 87, 659-797
2. Bours, M.J.; Dagnelie, P.C.; Giuliani, A.L.; Wesselius, A.; Di Virgilio, F. P2 receptors and extracellular ATP, a novel homeostatic pathway in inflammation. Front. Biosci. (Schol. Ed.), 2011, 3, 1443-1456
3. Hasko, G.; Linden, J.; Cronstein, B.; Pacher, P. Adenosine receptors, therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov., 2008, 7, 759-770
4. Pellegatti, P.; Raffaghello, L.; Bianchi, G.; Piccardi, F.; Pistoia, V.; Di Virgilio, F. Increased level of extracellular ATP at tumor sites, in vivo imaging with plasma membrane luciferase. PLoS ONE, 2008, 3, e2599
5. Falzoni, S.; Donvito, G.; Di Virgilio, F. Detecting adenosine triphosphate in the pericellular space. Interface Focus, 2013, 3, 2012.0101
6. Rayah, A.; Kanellopoulos, J.M.; Di Virgilio, F. P2 receptors and immunity. Microbes Infect., 2012, 14, 1254-1262
7. Junger, W.G. Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol., 2011, 11, 201-212
8. Idzko, M.; Ferrari, D.; Eltzschig, H.K. Nucleotide signalling during inflammation. Nature, 2014, 509, 310-317
9. Chvatchko, Y.; Valera, S.; Aubry, J.P.; Renno, T.; Buell, G.; Bonnefoy, J.Y. The involvement of an ATP-gated ion channel; P(2X1); in thymocyte apoptosis. Immunity, 1996, 5, 275-283
10. Woehrle, T.; Yip, L.; Elkhal, A.; Sumi, Y.; Chen, Y.; Yao, Y.; Insel, P.A.; Junger, W.G. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood, 2010, 116, 3475-3484
11. Ulmann, L.; Hirbec, H.; Rassendren, F. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J., 2010, 29, 2290-2300
12. Ferrari, D.; Pizzirani, C.; Adinolfi, E.; Lemoli, R.M.; Curti, A.; Idzko, M.; Panther, E.; Di Virgilio, F. The P2X7 receptor, a key player in IL-1 processing and release. J. Immunol., 2006, 176, 3877-3883
13. Tsuda, M.; Shigemoto-Mogami, Y.; Koizumi, S.; Mizokoshi, A.; Kohsaka, S.; Salter, M.W.; Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424, 778-783
14. Beggs, S.; Trang, T.; Salter, M.W. P2X4R+ microglia drive neuropathic pain. Nat. Neurosci., 2012, 15, 1068-1073
15. Ulmann, L.; Hatcher, J.P.; Hughes, J.P.; Chaumont, S.; Green, P.J.; Conquet, F.; Buell, G.N.; Reeve, A.J.; Chessell, I.P.; Rassendren, F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci., 2008, 28, 11263-11268
16. Skaper, S.D.; Giusti, P.; Facci L. Microglia and mast cells, two tracks on the road to neuroinflammation. FASEB J., 2014, 26, 3103-3117
17. Antonio, L.S.; Stewart, A.P.; Xu, X.J.; Varanda, W.A.; Murrell-Lagnado R.D.; Edwardson, J.M. P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. Br. J. Pharmacol., 2011, 163, 1069-1077
18. Perregaux, D.; Gabel, C.A. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem., 1994, 269, 15195-15203
19. Sanz J.M.; Di Virgilio, F. Kinetics and mechanism of ATPdependent IL-1 beta release from microglial cells. J. Immunol., 2000, 164, 4893-4898
20. Munoz-Planillo, R.; Kuffa, P.; Martinez-Colon, G.; Smith, B.L.; Rajendiran, T.M.; Nunez, G. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity, 2013, 38, 1142-1153
21. Di Virgilio, F.; Chiozzi, P.; Ferrari, D.; Falzoni, S.; Sanz, J.M.; Morelli, A.; Torboli, M.; Bolognesi, G.; Baricordi, O.R. Nucleotide receptors, an emerging family of regulatory molecules in blood cells. Blood, 2001, 97, 587-600
22. Koshi, R.; Coutinho-Silva, R.; Cascabulho, C.M.; Henrique-Pons, A.; Knight, G.E.; Loesch, A.; Burnstock, G. Presence of the P2X(7) purinergic receptor on immune cells that invade the rat endometrium during oestrus. J. Reprod. Immunol., 2005, 66, 127-140
23. Ferrari, D.; Idzko, M.; Dichmann, S.; Purlis, D.; Virchow, C.; Norgauer, J.; Chiozzi, P.; Di Virgilio, F.; Luttmann W. P2 purinergic receptors of human eosinophils, characterization and coupling to oxygen radical production. FEBS Lett., 2000, 486, 217-224
24. Lucattelli, M.; Cicko, S.; Muller, T.; Lommatzsch, M.; De Cunto, G.; Cardini, S.; Sundas, W.; Grimm, M.; Zeiser, R.; Durk, T.; Zissel, G.; Sorichter, S.; Ferrari, D.; Di Virgilio, F.; Virchow, J.C.; Lungarella, G.; Idzko, M. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am. J. Respir. Cell Mol. Biol., 2011, 44, 423-429
25. Wareham, K.; Vial, C.; Wykes, R.C.; Bradding, P.; Seward, E.P. Functional evidence for the expression of P2X1; P2X4 and P2X7 receptors in human lung mast cells. Br. J. Pharmacol., 2009, 157, 1215-1224
26. Bulanova, E.; Bulfone-Paus, S. P2 receptor-mediated signaling in mast cell biology. Purinergic Signal., 2010, 6, 3-17
27. Cockcroft, S.; Gomperts, B.D. The ATP4-receptor of rat mast cells. Biochem. J., 1980, 188, 789-798
28. Burnstock, G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov., 2008, 7, 575-590
29. Inoue, K. Purinergic systems in microglia. Cell. Mol. Life Sci., 2008, 65, 3074-3080
30. Burnstock, G.; Ralevic, V. Purinergic signaling and blood vessels in health and disease. Pharmacol. Rev., 2014, 66, 102-192
31. Hu, H.; Hoylaerts, M.F. The P2X1 ion channel in platelet function. Platelets, 2010, 21, 153-166
32. Bartlett, R.; Stokes, L.; Sluyter, R. The P2X7 receptor channel, recent developments and the use of P2X7 antagonists in models of disease. Pharmacol. Rev., 2014, 66, 638-675
33. Cabrini, G.; Falzoni, S.; Forchap, S.L.; Pellegatti, P.; Balboni, A.; Agostini, P.; Cuneo, A.; Castoldi, G.; Baricordi, O.R.; Di Virgilio, F. A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes. J. Immunol., 2005, 175, 82-89
34. Green, E.K.; Grozeva, D.; Raybould, R.; Elvidge, G.; Macgregor, S.; Craig, I.; Farmer, A.; McGuffin, P.; Forty, L.; Jones, L.; Jones, I.; O'Donovan, M.C.; Owen, M.J.; Kirov, G.; Craddock, N. P2RX7, A bipolar and unipolar disorder candidate susceptibility gene? Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2009, 150B, 1063-1069
35. Sperlagh, B.; Csolle, C.; Ando, R.D.; Goloncser, F.; Kittel, A.; Baranyi, M. The role of purinergic signaling in depressive disorders. Neuropsychopharmacol. Hung., 2012, 14, 231-238
36. Halmai, Z.; Dome, P.; Vereczkei, A.; Abdul-Rahman, O.; Szekely, A.; Gonda, X.; Faludi, G.; Sasvari-Szekely, M.; Nemoda, Z. Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms. J. Affect. Disord., 2013, 150, 104-109
37. Rassendren, F.; Buell, G.N.; Virginio, C.; Collo, G.; North, R.A.; Surprenant, A. The permeabilizing ATP receptor; P2X7. Cloning and expression of a human cDNA. J. Biol. Chem., 1997, 272, 5482-5486
38. Cheewatrakoolpong, B.; Gilchrest, H.; Anthes, J.C.; Greenfeder, S. Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem. Biophys. Res. Commun., 2005, 332, 17-27
39. Feng, Y.H.; Li, X.; Wang, L.; Zhou, L.; Gorodeski, G.I. A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J. Biol. Chem., 2006, 281, 17228-17237
40. Adinolfi, E.; Cirillo, M.; Woltersdorf, R.; Falzoni, S.; Chiozzi, P.; Pellegatti, P.; Callegari M.G.; Sandona, D.; Markwardt, F.; Schmalzing, G.; Di Virgilio, F. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J., 2010, 24, 3393-3404
41. Nicke, A.; Kuan, Y.H.; Masin, M.; Rettinger, J.; Marquez-Klaka, B.; Bender, O.; Gorecki, D.C.; Murrell-Lagnado, R.D.; Soto, F. A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J. Biol. Chem., 2009, 284, 25813-25822
42. Masin, M.; Young, C.; Lim, K.; Barnes, S.J.; Xu, X.J.; Marschall, V.; Brutkowski, W.; Mooney, E.R.; Gorecki, D.C.; Murrell-Lagnado, R. Expression; assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor, re-evaluation of P2X7 knockouts. Br. J. Pharmacol., 2012, 165, 978-993
43. Medzhitov, R. Origin and physiological roles of inflammation. Nature, 2008, 454, 428-435
44. Di Virgilio, F. The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol. Rev., 2013, 65, 872-905
45. Lopez-Castejon, G.; Pelegrin, P. Current status of inflammasome blockers as anti-inflammatory drugs. Expert. Opin. Investig. Drugs, 2012, 21, 995-1007
46. North, R.A. Molecular physiology of P2X receptors. Physiol. Rev., 2002, 82, 1013-1067
47. Sanz, J.M.; Chiozzi, P.; Ferrari, D.; Colaianna, M.; Idzko, M.; Falzoni, S.; Fellin, R.; Trabace, L.; Di Virgilio, F. Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J. Immunol., 2009, 182, 4378-4385
48. Niemi, K.; Teirila, L.; Lappalainen, J.; Rajamaki, K.; Baumann, M.H.; Oorni, K.; Wolff, H.; Kovanen, P.T.; Matikainen, S.; Eklund, K.K. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J. Immunol., 2011, 186, 6119-6128
49. Elssner, A.; Duncan, M.; Gavrilin, M.; Wewers, M.D. A novel P2X7 receptor activator; the human cathelicidin-derived peptide LL37; induces IL-1 beta processing and release. J. Immunol., 2004, 172, 4987-4994
50. Tomasinsig, L.; Pizzirani, C.; Skerlavaj, B.; Pellegatti, P.; Gulinelli, S.; Tossi, A.; Di Virgilio, F.; Zanetti, M. The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J. Biol. Chem., 2008, 283, 30471-30481
51. Homolya, L.; Steinberg, T.H.; Boucher, R.C. Cell to Cell Communication in Response to Mechanical Stress via Bilateral Release of ATP and UTP in Polarized Epithelia. J. Cell Biol., 2000, 150, 1349-1360
52. Yu, T.; Junger, W.G.; Yuan, C.; Jin, A.; Zhao, Y.; Zheng, X.; Zeng, Y.; Liu, J. Shockwaves increase T-cell proliferation and IL-2 expression through ATP release; P2X7 receptors; and FAK activation. Am. J. Physiol. Cell. Physiol., 2010, 298, C457-C464
53. Eleftheriadis, T.; Pissas, G.; Karioti, A.; Antoniadi, G.; Golfinopoulos, S.; Liakopoulos, V.; Mamara, A.; Speletas, M.; Koukoulis, G.; Stefanidis, I. Uric acid induces caspase-1 activation; IL-1beta secretion and P2X7 receptor dependent proliferation in primary human lymphocytes. Hippokratia, 2013, 17, 141-145
54. Yip, L.; Woehrle, T.; Corriden, R.; Hirsh, M.; Chen, Y.; Inoue, Y.; Ferrari, V.; Insel, P.A.; Junger, W.G. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J., 2009, 23, 1685-1693
55. Newbolt, A.; Stoop, R.; Virginio, C.; Surprenant, A.; North, R.A.; Buell, G.; Rassendren, F. Membrane topology of an ATP-gated ion channel (P2X receptor). J. Biol. Chem., 1998, 273, 15177-15182
56. Babelova, A.; Moreth, K.; Tsalastra-Greul, W.; Zeng-Brouwers, J.; Eickelberg, O.; Young, M.F.; Bruckner, P.; Pfeilschifter, J.; Schaefer, R.M.; Grone, H.J.; Schaefer, L. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J. Biol. Chem., 2009, 284, 24035-24048
57. Sakaki, H.; Fujiwaki, T.; Tsukimoto, M.; Kawano, A.; Harada, H.; Kojima, S. P2X4 receptor regulates P2X7 receptor-dependent IL-1beta and IL-18 release in mouse bone marrow-derived dendritic cells. Biochem. Biophys. Res. Commun., 2013, 432, 406-411
58. Barbera-Cremades, M.; Baroja-Mazo, A.; Gomez, A.I.; Machado, F.; Di Virgilio, F.; Pelegrin, P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J., 2012, 26, 2951-2962
59. Surprenant, A.; Rassendren, F.; Kawashima, E.; North, R.A.; Buell, G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science, 1996, 272, 735-738
60. Ferrari, D.; Villalba, M.; Chiozzi, P.; Falzoni, S.; Ricciardi-Castagnoli, P.; Di Virgilio, F. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol., 1996, 156, 1531-1539
61. Ferrari, D.; Chiozzi, P.; Falzoni, S.; Dal Susino, M.; Melchiorri, L.; Baricordi, O.R.; Di Virgilio, F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol., 1997, 159, 1451-1458
62. Perregaux, D.G.; McNiff, P.; Laliberte, R.; Conklyn, M.; Gabel, C.A. ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1{beta} and IL-18 in Human Blood. J. Immunol., 2000, 165, 4615-4623
63. Mehta, V.B.; Hart, J.; Wewers, M.D. ATP-stimulated release of interleukin (IL)-1 beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem., 2001, 276, 3820-3826
64. Pelegrin, P.; Barroso-Gutierrez, C.; Surprenant, A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J. Immunol., 2008, 180, 7147-7157
65. Solini, A.; Chiozzi, P.; Morelli, A.; Fellin, R.; Di Virgilio, F. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes; microvesicle formation and IL-6 release. J. Cell Sci., 1999, 112( Pt 3), 297-305
66. Caporali, F.; Capecchi, P.L.; Gamberucci, A.; Lazzerini, P.E.; Pompella, G.; Natale, M.; Lorenzini, S.; Selvi, E.; Galeazzi, M.; Laghi, P.F. Human rheumatoid synoviocytes express functional P2X7 receptors. J. Mol. Med. (Berl.), 2008, 86, 937-949
67. Madec, S.; Rossi, C.; Chiarugi, M.; Santini, E.; Salvati, A.; Ferrannini, E.; Solini, A. Adipocyte P2X7 receptors expression, a role in modulating inflammatory response in subjects with metabolic syndrome? Atherosclerosis, 2011, 219, 552-558
68. Shieh, C.H.; Heinrich, A.; Serchov, T.; van Calker, D.; Biber, K. P2X7-dependent, but differentially regulated release of IL-6; CCL2; and TNF-alpha in cultured mouse microglia. Glia, 2014, 62, 592-607
69. Caraccio, N.; Monzani, F.; Santini, E.; Cuccato, S.; Ferrari, D.; Callegari, M.G.; Gulinelli, S.; Pizzirani, C.; Di Virgilio, F.; Ferrannini, E.; Solini, A. Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology, 2005, 146, 3172-3178
70. Loomis, W.H.; Namiki, S.; Ostrom, R.S.; Insel, P.A.; Junger, W.G. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release; P2 receptor; and p38 MAPK activation. J. Biol. Chem., 2003, 278, 4590-4596
71. Hide, I.; Tanaka, M.; Inoue, A.; Nakajima, K.; Kohsaka, S.; Inoue, K.; Nakata, Y. Extracellular ATP triggers tumor necrosis factoralpha release from rat microglia. J. Neurochem., 2000, 75, 965-972
72. Ferrari, D.; La Sala, A.; Chiozzi, P.; Morelli, A.; Falzoni, S.; Girolomoni, G.; Idzko, M.; Dichmann, S.; Norgauer, J.; Di Virgilio, F. The P2 purinergic receptors of human dendritic cells, identification and coupling to cytokine release. FASEB J., 2000, 14, 2466-2476
73. Atarashi, K.; Nishimura, J.; Shima, T.; Umesaki, Y.; Yamamoto, M.; Onoue, M.; Yagita, H.; Ishii, N.; Evans, R.; Honda, K.; Takeda, K. ATP drives lamina propria T(H)17 cell differentiation. Nature, 2008, 455, 808-812
74. Schenk, U.; Frascoli, M.; Proietti, M.; Geffers, R.; Traggiai, E.; Buer, J.; Ricordi, C.; Westendorf, A.M.; Grassi F. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal., 2011, 4, ra12
75. Purvis, H.A.; Anderson, A.E.; Young, D.A.; Isaacs, J.D.; Hilkens, C.M. A Negative Feedback Loop Mediated by STAT3 Limits Human Th17 Responses. J. Immunol., 2014, 193, 1142-1150
76. Panenka, W.; Jijon, H.; Herx, L.M.; Armstrong, J.N.; Feighan, D.; Wei, T.; Yong, V.W.; Ransohoff, R.M.; MacVicar B.A. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci., 2001, 21, 7135-7142
77. Stokes, L.; Surprenant, A. Purinergic P2Y2 Receptors Induce Increased MCP-1/CCL2 Synthesis and Release from Rat Alveolar and Peritoneal Macrophages. J. Immunol., 2007, 179, 6016-6023
78. Kataoka, A.; Tozaki-Saitoh, H.; Koga, Y.; Tsuda, M.; Inoue, K. Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J. Neurochem., 2009, 108, 115-125
79. Trubiani, O.; Horenstein, A.L.; Caciagli, F.; Caputi, S.; Malavasi, F.; Ballerini, P. Expression of P2X7 ATP receptor mediating the IL8 and CCL20 release in human periodontal ligament stem cells. J. Cell Biochem., 2014, 115, 1138-1146
80. Wang, C.M.; Chang, Y.Y.; Sun, S.H. Activation of P2X7 purinoceptor-stimulated TGF-beta 1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line; RBA-2. Cell Signal., 2003, 15, 1129-1137
81. Bianchi, G.; Vuerich, M.; Pellegatti, P.; Marimpietri, D.; Emionite, L.; Marigo, I.; Bronte, V.; Di Virgilio, F.; Pistoia V.; Raffaghello, L. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. Cell Death. Dis., 2014, 5, e1135
82. Rizzo, R.; Ferrari, D.; Melchiorri, L.; Stignani, M.; Gulinelli, S.; Baricordi, O.R.; Di Virgilio, F. Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes. J. Immunol., 2009, 183, 4302-4311
83. Rizzo, R.; Audrito, V.; Vacca, P.; Rossi, D.; Brusa, D.; Stignani, M.; Bortolotti, D.; D'Arena, G.; Coscia, M.; Laurenti, L.; Forconi, F.; Gaidano, G.; Mingari, M.C.; Moretta, L.; Malavasi, F.; Deaglio, S. HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression, impact of the HLA-G 14 base pair (rs66554220) polymorphism. Haematologica, 2014, 99, 888-896
84. Hill, L.M.; Gavala, M.L.; Lenertz, L.Y.; Bertics, P.J. Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J. Immunol., 2010, 185, 3028-3034
85. Adinolfi, E.; Raffaghello, L.; Giuliani, A.L.; Cavazzini, L.; Capece, M.; Chiozzi, P.; Bianchi, G.; Kroemer, G.; Pistoia, V.; Di Virgilio, F. Expression of the P2X7 receptor increases in vivo tumor growth. Cancer Res., 2012, 72, 2957-2969
86. Ferrara, N. Vascular Endothelial Growth Factor, Basic Science and Clinical Progress. Endocr. Rev., 2004, 25, 581-611
87. Tarr, J.M.; Kaul, K.; Chopra, M.; Kohner, E.M.; Chibber, R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol., 2013, 343560
88. Holz, F.G.; Schmitz-Valckenberg, S.; Fleckenstein, M. Recent developments in the treatment of age-related macular degeneration. J. Clin. Invest., 2014, 124, 1430-1438
89. Ferrari, D.; Wesselborg, S.; Bauer, M.K.; Schulze-Osthoff, K. Extracellular ATP activates transcription factor NF-kappa B through the P2Z purinoreceptor by selectively targeting NF-kappa B p65. J. Cell Biol., 1997, 139, 1635-1643
90. Ferrari, D.; Stroh, C.; Schulze-Osthoff, K. P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J. Biol. Chem., 1999, 274, 13205-13210
91. Adinolfi, E.; Callegari, M.G.; Cirillo, M.; Pinton, P.; Giorgi, C.; Cavagna, D.; Rizzuto, R.; Di Virgilio, F. Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum; activates NFATc1 and protects from apoptosis. J. Biol. Chem., 2009, 284, 10120-10128
92. Amoroso, F.; Falzoni, S.; Adinolfi, E.; Ferrari, D.;Di Virgilio, F. The P2X7 receptor is a key modulator of aerobic glycolysis. Cell Death. Dis., 2012, 3, e370
93. Tafani, M.; Schito, L.; Pellegrini, L.; Villanova, L.; Marfe, G.; Anwar, T.; Rosa, R.; Indelicato, M.; Fini, M.; Pucci, B.; Russo, M.A. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis, 2011, 32, 1167-1175
94. Gutierrez-Vazquez, C.; Villarroya-Beltri, C.; Mittelbrunn, M.; Sanchez-Madrid, F. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol. Rev., 2013, 251, 125-142
95. Wilson, H.L.; Francis, S.E.; Dower, S.K.; Crossman, D.C. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J. Immunol., 2004, 173, 1202-1208
96. MacKenzie, A.; Wilson, H.L.; Kiss-Toth, E.; Dower, S.K.; North, R.A.; Surprenant, A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity, 2001, 15, 825-835
97. Pizzirani, C.; Ferrari, D.; Chiozzi, P.; Adinolfi, E.; Sandona, D.; Savaglio, E.; Di Virgilio, F. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood, 2007, 109, 3856-3864
98. Baroni, M.; Pizzirani, C.; Pinotti, M.; Ferrari, D.; Adinolfi, E.; Calzavarini, S.; Caruso, P.; Bernardi, F.; Di Virgilio, F. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J., 2007, 21, 1926-1933
99. Gulinelli, S.; Salaro, E.; Vuerich, M.; Bozzato, D.; Pizzirani, C.; Bolognesi, G.; Idzko, M.; Di Virgilio, F.; Ferrari, D. IL-18 associates to microvesicles shed from human macrophages by a LPS/TLR-4 independent mechanism in response to P2X receptor stimulation. Eur. J. Immunol., 2012, 42, 3334-3345
100. Yndestad, A.; Damas, J.K.; Oie, E.; Ueland, T.; Gullestad, L.; Aukrust, P. Systemic inflammation in heart failure-The whys and wherefores. Heart Fail. Rev., 2006, 11, 83-92
101. Solini, A.; Cuccato, S.; Ferrari, D.; Santini, E.; Gulinelli, S.; Callegari, M.G.; Dardano, A.; Faviana, P.; Madec, S.; Di Virgilio, F.; Monzani, F. Increased P2X7 receptor expression and function in thyroid papillary cancer, a new potential marker of the disease? Endocrinology, 2008, 149, 389-396
102. Slater, M.; Danieletto, S.; Gidley-Baird, A.; The, L.C.; Barden, J.A. Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology, 2004, 44, 206-215
103. Molloy, A.; Laochumroonvorapong, P.; Kaplan, G. Apoptosis; but not necrosis; of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J. Exp. Med., 1994, 180, 1499-1509
104. Lammas, D.A.; Stober, C.; Harvey, C.J.; Kendrick, N.; Panchalingam, S.; Kumararatne, D.S. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity, 1997, 7, 433-444
105. Kusner, D.J.; Adams, J. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J. Immunol., 2000, 164, 379-388
106. Saunders, B.M.; Fernando, S.L.; Sluyter, R.; Britton, W.J.; Wiley, J.S. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J. Immunol., 2003, 171, 5442-5446
107. Placido, R.; Auricchio, G.; Falzoni, S.; Battistini, L.; Colizzi, V.; Brunetti, E.; Di Virgilio, F.; Mancino, G. P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/ macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell. Immunol., 2006, 244, 10-18
108. Fernando, S.L.; Saunders, B.M.; Sluyter, R.; SkarRatt, K.K.; Goldberg, H.; Marks, G.B.; Wiley, J.S.; Britton, W.J. A polymorphism in the P2X7 gene increases susceptibility to extra pulmonary tuberculosis. Am. J. Respir. Crit. Care Med., 2007, 175, 360-366
109. Li, C.M.; Campbell, S.J.; Kumararatne, D.S.; Bellamy, R.; Ruwende, C.; McAdam, K.P.; Hill, A.V.; Lammas, D.A. Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J. Infect. Dis., 2002, 186, 1458-1462
110. Wu, G.; Zhao, M.; Gu, X.; Yao, Y.; Liu, H.; Song, Y. The effect of P2X7 receptor 1513 polymorphism on susceptibility to tuberculosis, a meta-analysis. Infect. Genet. Evol., 2014, 24, 82-91
111. Myers, A.J.; Eilertson, B.; Fulton, S.A.; Flynn, J.L.; Canaday, D.H. The purinergic P2X7 receptor is not required for control of pulmonary Mycobacterium tuberculosis infection. Infect. Immun., 2005, 73, 3192-3195
112. Nino-Moreno, P.; Portales-Perez, D.; Hernandez-Castro, B.; Portales-Cervantes, L.; Flores-Meraz, V.; Baranda, L.; Gomez-Gomez, A.; Acuna-Alonzo, V.; Granados, J.; Gonzalez-Amaro, R. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis. Clin. Exp. Immunol., 2007, 148, 469-477
113. Xiao, J.; Sun, L.; Jiao, W.; Li, Z.; Zhao, S.; Li, H.; Jin, J.; Jiao, A.; Guo, Y.; Jiang, Z.; Mokrousov, I.; Shen, A. Lack of association between polymorphisms in the P2X7 gene and tuberculosis in a Chinese Han population. FEMS Immunol. Med. Microbiol., 2009, 55, 107-111
114. Amaral, E.P.; Ribeiro, S.C.; Lanes, V.R.; Almeida, F.M.; de Andrade, M.R.; Bomfim, C.C.; Salles, E.M.; Bortoluci, K.R.; Coutinho-Silva, R.; Hirata, M.H.; Alvarez, J.M.; Lasunskaia, E.B.; D'Imperio-Lima, M.R. Pulmonary Infection with Hypervirulent Mycobacteria Reveals a Crucial Role for the P2X7 Receptor in Aggressive Forms of Tuberculosis. PLoS. Pathog., 2014, 10, e1004188
115. Falzoni, S.; Munerati, M.; Ferrari, D.; Spisani, S.; Moretti, S.; Di Virgilio, F. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J. Clin. Invest., 1995, 95, 1207-1216
116. Chiozzi, P.; Sanz, J.M.; Ferrari, D.; Falzoni, S.; Aleotti, A.; Buell, G.N.; Collo, G.; Di Virgilio, F. Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J. Cell Biol., 1997, 138, 697-706
117. Lemaire, I.; Falzoni, S.; Leduc, N.; Zhang, B.; Pellegatti, P.; Adinolfi, E.; Chiozzi, P.; Di Virgilio, F. Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells. J. Immunol., 2006, 177, 7257-7265
118. Pellegatti, P.; Falzoni, S.; Donvito, G.; Lemaire, I.; Di Virgilio, F. The P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration. FASEB J., 201, 25, 1264-1274
119. Coutinho-Silva, R.; Stahl, L.; Raymond, M.N.; Jungas, T.; Verbeke, P.; Burnstock, G.; Darville, T.; Ojcius, D.M. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity, 2003, 19, 403-412
120. Mantuano-Barradas, M.; Henriques-Pons, A.; Araujo-Jorge, T.C.; Di Virgilio, F.; Coutinho-Silva, R.; Persechini, P.M. Extracellular ATP induces cell death in CD4+/CD8+ double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes. Infect., 2003, 5, 1363-1371
121. Lees, M.P.; Fuller, S.J.; McLeod, R.; Boulter, N.R.; Miller, C.M.; Zakrzewski, A.M.; Mui, E.J.; Witola, W.H.; Coyne, J.J.; Hargrave, A.C.; Jamieson, S.E.; Blackwell, J.M.; Wiley, J.S.; Smith, N.C. P2X7 receptor-mediated killing of an intracellular parasite; Toxoplasma gondii; by human and murine macrophages. J. Immunol., 2010, 184, 7040-7046
122. Chaves, S.P.; Torres-Santos, E.C.; Marques, C.; Figliuolo, V.R.; Persechini, P.M.; Coutinho-Silva, R.; Rossi-Bergmann, B. Modulation of P2X(7) purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination. Microbes. Infect., 2009, 11, 842-849
123. Loike, J.D.; Kozler, V.F.; Silverstein, S.C. Increased ATP and creatine phosphate turnover in phagocytosing mouse peritoneal macrophages. J. Biol. Chem., 1979, 254, 9558-9564
124. Koizumi, S.; Shigemoto-Mogami, Y.; Nasu-Tada, K.; Shinozaki, Y.; Ohsawa, K.; Tsuda, M.; Joshi, B.V.; Jacobson, K.A.; Kohsaka, S.; Inoue, K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature, 2007, 446, 1091-1095
125. Gu, B.J.; Saunders, B.M.; Jursik, C.; Wiley, J.S. The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP. Blood, 2010, 115, 1621-1631
126. Gu, B.J.; Saunders, B.M.; Petrou, S.; Wiley, J.S. P2X(7) is a scavenger receptor for apoptotic cells in the absence of its ligand; extracellular ATP. J. Immunol., 2011, 187, 2365-2375
127. Baricordi, O.R.; Ferrari, D.; Melchiorri, L.; Chiozzi, P.; Hanau, S.; Chiari, E.; Rubini, M.; Di Virgilio, F. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood, 1996, 87, 682-690
128. Schenk, U.; Westendorf, A.M.; Radaelli, E.; Casati, A.; Ferro M.; Fumagalli, M.; Verderio, C.; Buer, J.; Scanziani, E.; Grassi, F. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci. Signal., 2008, 1, ra6
129. Daniel, C.; Wennhold, K.; Kim, H.J.;von Boemer, H. Enhancement of antigen-specific Treg vaccination in vivo. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 16246-16251
130. Trabanelli, S.; Ocadlikova, D.; Gulinelli, S.; Curti, A.; Salvestrini, V.; Vieira, R.P.; Idzko, M.; Di Virgilio, F.; Ferrari, D.; Lemoli, R.M. Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation. J. Immunol., 2012, 189, 1303-1310
131. Rissiek, B.; Danquah, W.; Haag, F.; Koch-Nolte, F. Technical Advance, a new cell preparation strategy that greatly improves the yield of vital and functional Tregs and NKT cells. J. Leukoc. Biol., 2014, 95, 543-549
132. Casati, A.; Frascoli, M.; Traggiai, E.; Proietti, M.; Schenk, U.; Grassi, F. Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP. Cell Death. Differ., 2011, 18, 396-404
133. Mutini, C.; Falzoni, S.; Ferrari, D.; Chiozzi, P.; Morelli, A.; Baricordi, O.R.; Collo, G.; Ricciardi-Castagnoli, P.; Di Virgilio, F. Mouse dendritic cells express the P2X7 purinergic receptor, characterization and possible participation in antigen presentation. J. Immunol., 1999, 163, 1958-1965
134. Ghiringhelli, F.; Apetoh, L.; Tesniere, A.; Aymeric, L.; Ma, Y.; Ortiz, C.; Vermaelen, K.; Panaretakis, T.; Mignot, G.; Ullrich, E.;Perfettini, J.L.; Schlemmer, F.; Tasdemir, E.; Uhl, M.; Genin, P.; Civas, A.; Ryffel, B.; Kanellopoulos, J.; Tchopp, J.; Andrè, F.; Liderau, R.; McLaughlin, N.M; Haynes, N.M.; Smyth, M.J.; Kroemer, G.; Zitvogel, L. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med., 2009, 15, 1170-1178
135. Baricordi, O.R.; Melchiorri, L.; Adinolfi, E.; Falzoni, S.; Chiozzi, P.; Buell, G.; Di Virgilio, F. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J. Biol. Chem., 1999, 274, 33206-33208
136. Adinolfi, E.; Callegari, M.G.; Ferrari, D.; Bolognesi, C.; Minelli, M.; Wieckowski, M.R.; Pinton, P.; Rizzuto, R.; Di Virgilio, F. Basal Activation of the P2X7 ATP Receptor Elevates Mitochondrial Calcium and Potential; Increases Cellular ATP Levels; and Promotes Serum-independent Growth. Mol. Biol. Cell, 2005, 16, 3260-3272
137. Bianco, F.; Ceruti, S.; Colombo, A.; Fumagalli, M.; Ferrari, D.; Pizzirani, C.; Matteoli, M.; Di Virgilio, F.; Abbracchio, M.P.;Verderio, C. A role for P2X7 in microglial proliferation. J. Neurochem., 2006, 99, 745-758
138. Monif, M.; Reid, C.A.; Powell, K.L.; Smart, M.L.; Williams, D.A. The P2X7 Receptor Drives Microglial Activation and Proliferation, A. Trophic Role for P2X7R Pore. J. Neurosci., 2009, 29, 3781-3791
139. Inoue, K.; Tsuda, M.; Koizumi, S. ATP-and adenosine-mediated signaling in the central nervous system, chronic pain and microglia, involvement of the ATP receptor P2X4. J. Pharmacol. Sci., 2004, 94, 112-114
140. Trang, T.; Salter, M.W. P2X4 purinoceptor signaling in chronic pain. Purinergic. Signal., 2012, 8, 621-628
141. Tsuda, M.; Masuda, T.; Tozaki-Saitoh, H.; Inoue, K. P2X4 receptors and neuropathic pain. Front. Cell Neurosci., 2013, 7, 191
142. Dell'Antonio, G.; Quattrini, A.; Dal, C.E.; Fulgenzi, A.; Ferrero, M.E. Antinociceptive effect of a new P(2Z)/P2X7 antagonist; oxidized ATP; in arthritic rats. Neurosci. Lett., 2002, 327, 87-90
143. Dell'Antonio, G.; Quattrini, A.; Cin, E.D.; Fulgenzi, A.; Ferrero, M.E. Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor; oxidized ATP. Arthritis Rheum., 2002, 46, 3378-3385
144. Chessell, I.P.; Hatcher, J.P.; Bountra, C.; Michel, A.D.; Hughes, J.P.; Green, P.; Egerton, J.; Murfin, M.; Richardson, J.; Peck, W.L.; Grahames, C.B.; Casula, M.A.; Yiangou, Y.; Birch, R.; Anand, P.; Buell, G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain, 2005, 114, 386-396
145. Chessell, I.; Hatcher, J.; Billinton, A. Mechanistic differentiation of cancer pain, a pivotal role of P2X7 is absent. Pain, 2011, 152, 1703-1704
146. Sorge, R.E.; Trang, T.; Dorfman, R.; Smith, S.B.; Beggs, S.; Ritchie, J.; Austin, J.S.; Zaykin, D.V.; Vander Meulen, H.; Costigan, M.; Herbert, T.A.; Yarkoni-Abitbul, M; Tichauer, D.; Livneh, J.; Gershon, E.; Zheng, M.; Tan, K.; John, S.L.; Slade, G.D.; Jordan, J.; Woolf, C.J.; Peltz, G.; Maixner, W.; Diatchenko, L.; Seltzer, Z.; Salter, M.W.; Mogil, J.S. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat. Med., 2012, 18, 595-599
147. Burnstock, G. Purinergic mechanisms and pain-an update. Eur. J. Pharmacol., 2013, 716, 24-40
148. Martinon, F.; Burns, K.; Tschopp, J. The inflammasome, a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell., 2002, 10, 417-426
149. Bortner, C.D.; Hughes, F.M.; Jr.; Cidlowski, J.A. A primary role for K+ and Na+ efflux in the activation of apoptosis. J. Biol. Chem., 1997, 272, 32436-32442
150. Lee, G.S.; Subramanian, N.; Kim, A.I.; Aksentijevich, I.; Goldbach Mansky, R.; Sacks, D.B.; Germain, R.N.; Kastner, D.L.; Chae, J.J. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature, 2012, 492, 123-127
151. Zanovello, P.; Bronte, V.; Rosato, A.; Pizzo, P.; Di Virgilio, F. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J. Immunol., 1990, 145, 1545-1550
152. Alzola, E.; Perez-Etxebarria, A.; Kabre, E.; Fogarty, D.J.; Metioui, M.; Chaib, N.; Macarulla, J.M.; Matute, C.; Dehaye, J.P.; Marino, A. Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calciumindependent PLA2 with kallikrein secretion. J. Biol. Chem., 1998, 273, 30208-30217
153. Witting, A.; Walter, L.; Wacker, J.; Moller, T.; Stella, N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc. Natl. Acad. Sci. U.S.A., 2004, 101, 3214-3219
154. Fernando, K.C.; Gargett, C.E.; Wiley, J.S. Activation of the P2Z/P2X7 receptor in human lymphocytes produces a delayed permeability lesion, involvement of phospholipase D. Arch. Biochem. Biophys., 1999, 362, 197-202
155. Denlinger, L.C.; Fisette, P.L.; Sommer, J.A.; Watters, J.J.; Prabhu, U.; Dubyak, G.R.; Proctor, R.A.; Bertics, P.J. Cutting edge, the nucleotide receptor P2X7 contains multiple protein-and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol., 2001, 167, 1871-1876
156. Adinolfi, E.; Kim, M.; Young, M.T.; Di Virgilio, F.; Surprenant, A. Tyrosine Phosphorylation of HSP90 within the P2X7 Receptor Complex Negatively Regulates P2X7 Receptors. J. Biol. Chem., 2003, 278, 37344-37351
157. Pelegrin, P.; Surprenant, A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J., 2006, 25, 5071-5082
158. Yan, Z.; Li, S.; Liang, Z.; Tomic, M.;Stojilkovic, S.S. The P2X7 receptor channel pore dilates under physiological ion conditions. J. Gen. Physiol., 2008, 132, 563-573
159. Ferrari, D.; Pizzirani, C.; Gulinelli, S.; Callegari, G.; Chiozzi, P.; Idzko, M.; Panther, E.; Di Virgilio, F. Modulation of P2X7 receptor functions by polymyxin B, crucial role of the hydrophobic tail of the antibiotic molecule. Br. J. Pharmacol., 2007, 150, 445-454
160. Qureshi, O.S.; Paramasivam, A.; Yu, J.C.; Murrell-Lagnado, R.D. Regulation of P2X4 receptors by lysosomal targeting; glycan protection and exocytosis. J. Cell Sci., 2007, 120, 3838-3849
161. Toyomitsu, E.; Tsuda, M.; Yamashita, T.; Tozaki-Saitoh, H.; Tanaka, Y.; Inoue, K. CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signal., 2012, 8, 301-310
162. Trang, T.; Beggs, S.; Salter, M.W. Brain-derived neurotrophic factor from microglia, a molecular substrate for neuropathic pain. Neuron Glia Biol., 2011, 7, 99-108.